Humasis ranked among the top searched stocks on 4 days within the past month.

As of 9:30 AM on the 18th, Humasis is trading at 6,780 KRW, up 25.56% from the previous day. This represents a 112.87% increase compared to June 9. Humasis is known as an in vitro diagnostic device company.

Over the past 5 days, individual investors have net sold 15,883 shares, while foreigners and institutions have net bought 84,423 shares and net sold 360,954 shares, respectively.

On June 17, Humasis was a market topic with the headline "Celltrion and Humasis continue strong performance in targeting the COVID-19 market for the second day."

※Source: AI Investment Assistant AI Lassi

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing